Rexis Biotech's mission is to help people live healthier, more fulfilled lives through the production and national distribution of effective, great-tasting consumables. We believe these products should be widely available and, more importantly, affordable for all. Rexis is offering equity in their company to help fuel our rapid growth and delivery of pre-production purchase orders in hand.

Year Founded: 2021
CEO: Keith Bushfield
Headquarters: Ft. Lauderdale, FL

Industry: Biotech
Backing: $500k+ initial seed round investment from Virgin Beverages, 3CHI Group, The Manning Foundation
Traction: Signed contracts in the first half of 2023 worth over USD $8,350,000

Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information. Benzinga is compensated by the issuer for publicizing the offering of the issuer’s securities.